top of page

News

May 27, 2026 8:00 AM Eastern Daylight Time

Retension Pharmaceuticals Appoints Alison Schecter, M.D., as Chief Medical Officer and Alex Schwartz as Chief Financial Officer

Read Full Press Release  ...

August 21, 2024 07:00 AM Eastern Daylight Time

Retension Pharmaceuticals Closes $10.4 Million Oversubscribed Series A to Fund Clinical Trials for Patients Suffering from Resistant and Uncontrolled Hypertension

Read Full Press Release  ...

bottom of page